Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Rosenwald Lindsay A Md
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   37,641,451    

Indirect Shares

  13,489,834      
Direct Value   $67,210,463    

Indirect Value

  $47,517,396      
Total Shares   51,131,285      
Total Value   $114,727,858      


Genta Inc De
 $0 TG Therapeutics Inc
 $43,183,932 Keryx Biopharmaceuticals Inc
 $0 Alaunos Therapeutics
 $80,368 Chem Rx Corporation
 $0 Velcera Inc
 $0 Fortress Biotech, Inc.
 $822,512 National Holdings Corp
 $22,872,520 Checkpoint Therapeutics, Inc.
 $251,131 Avenue Therapeutics, Inc.
 $0 Journey Medical Ord Shs
 $0 Genta Inc De
 $0 TG Therapeutics Inc
 $43,183,932 Keryx Biopharmaceuticals Inc
 $0 Alaunos Therapeutics
 $80,368 Chem Rx Corporation
 $0 Velcera Inc
 $0 Fortress Biotech, Inc.
 $822,512 National Holdings Corp
 $22,872,520 Checkpoint Therapeutics, Inc.
 $251,131 Avenue Therapeutics, Inc.
 $0 Journey Medical Ord Shs
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    8   
    0    

     Stock price went up :

    2   
    0    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -25.3%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genta Inc De GNTAQ 10% Owner 2003-07-14 21,531,885 2004-02-13 656,191    Premium*  
            Soligenix Inc Common SNGX 10% Owner 2004-02-12 0 2004-02-12 3,230,922    Premium*  
            TG Therapeutics Inc TGTX 10% Owner 2005-05-11 2,649,321 2005-05-11 2,682,507    Premium*  
            Cypress Bioscience Inc CYPB 10% Owner 2004-01-09 0 2004-01-13 2,210,848    Premium*  
            Keryx Biopharmaceuticals Inc KERX Director 2006-05-22 1,735,863 2006-05-22 320,786    Premium*  
            Alaunos Therapeutics TCRT 10% Owner 2005-09-13 476,678 2005-09-13 737,777    Premium*  
            Chem Rx Corporation CHRXU Officer, Director, 10%... 2005-10-21 584,375 2005-10-21 584,375    Premium*  
            Velcera Inc VLCR 10% Owner 2006-01-17 121,205 0    Premium*  
            Fortress Biotech, Inc. FBIO President, CEO & Chair... 2024-05-16 2,873,905 2017-01-01 2,367,666    Premium*  
            National Holdings Corp NHLD 10% Owner 2016-09-12 7,037,482 2016-09-12 522,292    Premium*  
            Checkpoint Therapeutics, Inc. CKPT Director 2024-05-14 132,174 2017-07-10 0    Premium*  
            Avenue Therapeutics, Inc. ATXI Director 2023-09-08 354,318 0    Premium*  
            Journey Medical Ord Shs DERM Director 2024-03-25 144,245 2024-03-25 176,470    Premium*  
* Premium Members only  

Records found :    165         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2017-10-05 4 B $5.60 $19,880 D/D 3,550 15,750 2.39 -
TGTX TG Therapeutics Inc 10% Owner   –       –       •   2005-01-10 4 B $1.05 $21,150 D/D 20,000 2,310,521 2.37 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-08 4 B $4.34 $22,716 D/D 5,234 25,234 2.39 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-08 4/A B $4.34 $22,727 D/D 5,234 70,000 2.39 -
TGTX TG Therapeutics Inc 10% Owner   –       –       •   2005-01-24 4 B $1.27 $23,725 D/D 17,500 2,425,621 2.37 -
TGTX TG Therapeutics Inc 10% Owner   –       –       •   2005-01-20 4 B $1.02 $26,000 D/D 25,000 2,385,521 2.37 -
FBIO Fortress Biotech, Inc. President, CEO & Chairman   •       •       •   2023-09-26 4 B $0.28 $28,330 D/D 100,000 15,449,091 3.23 %
TGTX TG Therapeutics Inc 10% Owner   –       –       •   2005-01-21 4 B $1.28 $29,392 D/D 22,600 2,408,121 2.37 -
DERM Journey Medical Ord Shs Director   –       •      –    2024-03-25 4 B $3.04 $30,400 D/D 10,000 144,245 2.39 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-05 4/A B $4.28 $35,949 D/D 8,400 40,866 2.39 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-01 4/A B $4.15 $36,003 D/D 8,666 28,666 2.39 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-06 4/A B $4.35 $39,576 D/D 9,100 49,966 2.39 -
ATXI Avenue Therapeutics, Inc. Director   –       •      –    2018-06-07 4/A B $4.32 $63,969 D/D 14,800 64,766 2.39 -
GNTAQ Genta Inc De 10% Owner   –       –       •   2003-07-14 4 B $13.39 $66,950 D/D 5,000 21,531,885 2.45 -
FBIO Fortress Biotech, Inc. PRESIDENT, CEO & CHAIRMAN   •       •       •   2022-12-01 4 B $0.68 $67,960 D/D 100,000 11,730,324 3.23 %
DERM Journey Medical Ord Shs Director   –       •      –    2024-03-22 4 B $3.40 $68,000 D/D 20,000 134,245 2.39 -
FBIO Fortress Biotech, Inc. PRESIDENT, CEO & CHAIRMAN   •       •       •   2022-10-21 4 B $0.70 $69,500 D/D 100,000 11,625,324 3.23 %
GNTAQ Genta Inc De 10% Owner   –       –       •   2003-07-10 4 B $14.69 $73,450 D/D 5,000 21,526,885 2.45 -
FBIO Fortress Biotech, Inc. President, CEO & Chairman   •       •       •   2023-08-18 4 B $9.34 $93,400 D/D 10,000 112,500 3.23 %
CKPT Checkpoint Therapeutics, ... Director   –       •      –    2018-11-08 4 B $2.24 $108,044 D/D 48,234 76,782 2.39 -
CKPT Checkpoint Therapeutics, ... Director   –       •      –    2018-11-09 4 B $2.35 $116,715 D/D 49,666 126,448 2.39 -
FBIO Fortress Biotech, Inc. President, CEO & Chairman   •       •       •   2023-08-17 4 B $11.75 $117,500 D/D 10,000 102,500 3.23 %
FBIO Fortress Biotech, Inc. President, CEO & Chairman   •       •       •   2024-01-05 4 B $2.38 $118,770 D/D 50,000 2,863,905 3.23 -
CKPT Checkpoint Therapeutics, ... Director   –       •      –    2019-11-20 4 B $1.27 $127,000 D/D 100,000 237,890 2.39 -
DERM Journey Medical Ord Shs Director   –       •      –    2023-09-06 4 B $2.23 $223,000 D/D 100,000 114,245 2.39 -

  165  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed